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Summary 
Permanent disability of patients suffering from central nervous system (CNS) inflammation such 
as multiple sclerosis (MS), the most common chronic inflammatory disorder of the CNS, 
originates mainly from demyelination and axonal damage.  
Among other immune mediators, autoaggressive, cytotoxic CD8+ T cells have received 
increasing attention over the past years in MS pathogenesis. Yet, it has remained elusive whether 
axonal injury is the result of a CD8+ T cell-targeted hit against the axon itself or the consequence 
of an attack against the myelin structure. To address this issue, we traced the interaction of 
autoaggressive CD8+ T cells with living CNS tissue preserved in organotypic cerebellar brain 
slices by continuous confocal imaging. We restricted cognate antigen expression to the cytosol of 
oligodendrocytes to exclude its direct presentation by other CNS cell types. Using this model 
system of CNS inflammation, we visualized that axonal loss can be the consequence from 
"collateral bystander damage" by autoaggressive CD8+ T cells, targeting their cognate antigen 
processed and presented by oligodendrocytes. 
In a similar experimental set-up, we investigated myelin formation in the CNS. In general, its 
understanding appears closely connected with the regenerative process of remyelination after 
pathological demyelination like in MS and represents a challenging problem in view of the 
concerns towards the currently most accepted myelination model. We therefore performed a 
comprehensive live imaging, light and electron microscopy study of myelin formation in mouse 
CNS. Based on our data, we suggest a new mechanism of myelination, “The liquid croissant 
model”. Our new myelination concept does not only resolve the current, most suspected 
concerns and plausibly explains previous observations but attributes a new role to the axon, the 
 IV 
guidance of myelination. We believe that our model reshapes the current understanding of 
myelination and may help to explain myelination deficits in remyelination and axonopathies. 
 V 
Zusammenfassung 
Entzündungen im zentralen Nervensystem (ZNS), unter denen die Multiple Sklerose (MS) am 
häufigsten vorkommt, sind oft mit permanenter, neurologischer Behinderung verbunden. Diese  
kann oft auf den Verlust von Myelin (Demyelinisierung) und Axonen zurückgeführt werden. 
Neben anderen in der MS Pathogenese beteiligten Immunmediatoren sind autoagressive, 
zytotoxische CD8+ T Zellen in den letzten Jahren in den Mittelpunkt gerückt. Dennoch blieb es 
unklar, ob der axonale Schaden direkt durch CD8+ T Zellen entstehen könne oder ob er aus 
deren Angriff auf das Myelin resultiere. Um dies aufzuklären, haben wir mittels konfokaler 
Livemikroskopie autoagressive CD8+ T Zellen in organotypischen ZNS Gewebeschnittkulturen 
beobachtet. Dabei haben wir die Expression des kognitiven Antigens auf das Zytosol von 
Oligodendrozyten beschränkt, um eine direkte Präsentation durch Axone auszuschließen. 
Anhand dieses ZNS-Entzündungsmodells konnten wir zeigen, das Antigenpräsentation durch 
Oligodendrozyten einen axonalen Kollateralschaden durch CD8+ T Zellen hervorrufen kann. 
Anhand eines ähnlichen experimentellen Modells, haben wir die Entstehung des Myelins im 
ZNS untersucht. Generell ist das Verständnis der Myelinisierung nicht nur eng mit dem der 
Remyelinisierung nach einer pathologischen Demyelinisierung wie z. B. in der MS verknüpft, 
sondern stellt auch ein interessantes Problem in Anbetracht der Zweifel am jetzigen 
Myelinisierungsmodell dar. Wir haben daher eine umfassende live-, licht- und elektronen-
mikroskopische Studie der Myelinisierung im ZNS der Maus durchgeführt. Unseren Ergebnissen 
zufolge haben wir eine neue Myelinisierungshypothese formuliert, das „flüssige Croissant-
Modell“. Damit können nicht nur die größten Zweifel der bisherigen Myeliniserungstheorie 
gelöst und vorherige Beobachtungen erklärt werden, sondern das Axon selbst erhält eine neue 
 VI 
Aufgabe, indem es die Myeliniserung lenkt, was eine wesentliche Rolle bei Defiziten während 
der Remyelinisierung oder in Axonopathien spielen könnte. 
Introduction 
7 
1 Introduction 
1.1 Overview 
Given the still limited treatment options in many neurological diseases, the study of 
(patho)physiological processes in the central nervous system (CNS) is of major importance. In 
this regard, only investigation in real time with resolution in the micrometer range allows 
answering certain research questions but has been challenging to fulfill, especially in the CNS. 
We have therefore established high-resolution confocal live imaging of CNS tissue by employing 
organotypic cerebellar slice cultures (OCS) as a model system, where the CNS cytoarchitecture 
is preserved in-vitro and where certain conditions can be applied in a defined manner. In view of 
the high portion of patients suffering from multiple sclerosis (MS), where long-term neurological 
deficits appear to result from demyelination and axonal damage, we (1) established a model of 
CNS inflammation, where CD8+ T cells can be observed in real-time to destroy myelinated 
axons and (2) studied the process of myelin formation in its dynamic phase, which may help to 
understand the failure of regenerative processes, such as remyelination also seen in MS. 
1.2 Clinical signs and pathogenesis of Multiple Sclerosis 
More than 100 years ago, Charcot and others described MS by its clinical symptoms and 
pathological characteristics. Nowadays, MS is the most common inflammatory disorder of the 
CNS, thought to be caused by an immune response against components of myelin. It appears to 
affect genetically prone individuals most likely after exposure to an environmental trigger. Its 
prevalence is the highest in civilized countries the furthest away from the equator, like northern 
Europe, southern Australia, and North America and it affects patients in their second or third 
decade in life with a female predominance of 2:1 
1
. 
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Clinically, MS shows in most cases an alternation of relapses (episodes of demyelination and 
inflammation) followed by remissions (remyelination and plasticity), and is thus referred to as 
relapsing-remitting MS. During the relapse phase the neurological symptoms depend on the site 
of lesion but may include sensory loss, weakness in leg muscles, speech difficulties, loss of 
coordination and dizziness. The majority of the relapse-remitting MS patients will experience 
eventually a secondary progressive disorder with continuous neurological deficits lacking any 
remission phase, most likely due to less effective remyelination over time 
2
. In contrast, some 
patients develop primary progressive MS without any remission from the start of the disease. 
These patients often suffer from an upper motor-neuron syndrome of the legs that worsens 
gradually and becomes combined with various other concomitant symptoms 
1
. The typical 
diagnostic process consists of the clinical criteria together with (1) assessment of the Expanded 
Disability Status Scale (EDSS), (2) visual and sensory evoked potentials 
3
,(3) cerebrospinal fluid 
(CSF) analysis, where an intrathecal synthesis of immunoglobulins (Ig) can often be observed 
with oligoclonal bands representing IgGs and (4).magnetic resonance imaging (MRI) with 
multifocal lesions especially in the periventricular white matter, brain stem, cerebellum and 
spinal cord. 
Yet, the exact pathophysiological causes for disease’s initiation and perpetuation are far from 
being understood. Detailed histological studies of MS brain tissue indicate that different disease 
mechanisms may prevail in individual subgroups of MS patients 
4
 and that the disease consists of 
an inflammatory and degenerative phase 
5
. In general, the pathological hallmarks of acute MS 
lesions contain members of both innate and adaptive immunity (see later) and feature 
perivascular lymphocyte cell infiltrates, parenchymal edema, demyelinating plaques with loss of 
oligodendrocytes (OLG), axonal damage, myelin-laden macrophages, hypertrophic astrocytes in 
Introduction 
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brain and spinal cord 
6
. However, it has remained enigmatic, which of these immune components 
are the key players in MS pathophysiology. 
1.3 The immune system with an emphasis on T cell-mediated autoimmunity 
Cell-mediated events in the immunopathology of MS development are clearly important and 
have been shown to play a crucial role also in other organ-specific autoimmune diseases 
7
. As 
one part of this thesis focused on the role of CD8+ T cells in CNS inflammation, I will briefly 
discuss the workings on the immune system relevant to understand T cell self-tolerance, 
activation and autoimmunity. 
1.3.1 The immune system 
Virtually every organism comes with a system that protects it from pathogenic invasion of 
foreign molecules. In case of higher vertebrates the immune system exists of two branches, 
termed the innate and adaptive immune systems 
8
. In concert, they defend the organism but have 
different tasks assigned: Whereas innate immunity responds rapidly to antigens at the expense of 
specificity, acquired or adaptive immunity is specific and generates immunological memory. 
1.3.2 Innate immunity 
The innate immune system 
9
 comprises natural killer (NK) cells, / T cells, polymorphonuclear 
leukocytes (PMNs) and professional antigen presenting cells (APCs) like monocytes/ 
macrophages and dendritic cells (DCs). These defend the host against pathogens by recognizing 
specific molecular components of invading micro-organisms, known as pathogen-associated 
molecular patterns (PAMP). The discrimination of self versus non-self relies on the fact that 
PAMPs are absent in the host but are indispensable of the invading pathogen. To recognize 
PAMPs, innate immune cells hold germ-line encoded receptors called pattern recognition 
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receptors (PRR) 
10
. PRRs can be either in a soluble form like mannose-binding lectins (MBL) 
11
, 
C-reactive protein (CRP) 
12
 and complement 
13
 or they can be membrane bound receptors like 
the scavenger receptors 
14
 and the key structures of recognition, the toll-like receptors (TLR) 
15
, 
usually present on APCs. The different TLRs respond to bacteria, viruses, fungi or protozoa with 
increased phagocytic activity, release of inflammatory mediators, production of reactive oxygen 
species and secretion of cytokines. The secreted cytokine profile can crucially steer the 
subsequent adaptive immune response (see later). 
1.3.3 Adaptive immunity  
T and B lymphocytes are the cells of the adaptive immune system that mediate either humoral (B 
cells) or cellular (T cells) immunity. They recognize foreign structures through highly specific 
receptors, generated by somatic recombination. Their ability to form immunological memory 
upon antigen encounter allows a faster response, with greater reactivity, upon a second antigen 
hit. They both derive from bone marrow hematopoietic stem cells but follow different paths for 
their “education” in distinguishing self and non-self. 
1.3.4 Formation of T cell self-tolerance  
In the case of T cells, they migrate to the thymus, where they rearrange the alpha and beta chains 
of the T cell receptor (TCR) during maturation. In order to recognize the body’s own cells in the 
context of antigens, T cells become selected during a process called central tolerance 
16
: (1) to 
ensure the recognition of self-MHC, only the T cells that recognize self-MHC molecules 
expressed on thymic epithelial cells (TECs) are positively selected, non-recognition results in 
apoptosis. This part of selection is referred to as self-restriction by positive-selection. (2) In a 
second step termed negative selection, T cells “learn” to recognize foreign antigen. Here, 
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medullary TECs or specialized DCs express many tissue-restricted auto-antigens on self-MHC 
17
. Highly self-affine T cells become largely deleted, while receptor editing also occurs 
18
. T cells 
with a low affinity response survive and are released into the periphery. 
Although the mechanism of central tolerance is aimed at the deletion of self-recognizing T cells, 
it is not faultless. As a result, next to T cells that survived both positive and negative selection, 
potentially auto-reactive lymphocytes are released and may circulate in a naïve stage in the 
body’s blood and lymph streams. Therefore, to ensure a healthy immune system, several control 
mechanisms exist that are collectively referred to as peripheral tolerance: (1) potentially harmful 
cells are rendered anergic (functionally unresponsiveness) or become (2) deleted (apoptotic cell 
death) or (3) are suppressed by regulatory T cells (Tregs) that were identified in CD25+ depletion 
experiments 
19,20
. That these mechanisms work and that auto-reactive and protective T cells 
coexist was demonstrated in similar numbers of myelin-reactive CD4+ T cells in the blood and 
CSF of MS patients and healthy individuals 
21
, suggesting that environmental factors contribute 
to the development of autoimmunity (see below).  
1.3.5 T cell activation 
T lymphocytes are distinguished according to their TCR co-receptors in CD4+ and CD8+ T 
cells. They recognize processed peptide antigens only when presented on self-MHC molecules 
22
 
in the following manner: CD8+ T cells react to peptides bound on MHC class I molecules, 
expressed by virtually all nucleated cells of the body. MHC class I molecules present cell 
endogenous peptides, which is not only important for self-recognition but also to present 
intracellular pathogens (i.e. viruses). In contrast, CD4+ T cells recognize exogenous peptides 
presented by MHC class II molecules, expressed only by professional APCs. In a link between 
innate and adaptive immunity, APCs activate T cells in a process called priming by providing: a 
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suitable MHC/peptide complex interacting with the TCR (signal 1) and an additional co-
stimulatory signal like CD80 or CD86, which interacts with the T cell’s CD28 molecule (signal 
2). Depending on the co-stimulatory molecules of APCs that interact with their respective 
receptors on T cell, the signal is either stimulatory or inhibitory. Activation of T cells without co-
stimulation may lead to T cell anergy or deletion. 
The cytokine pattern secreted by APCs upon T cell encounter (signal 3) essentially influences the 
outcome of the T cell immune response. Consequently, CD4+ T cells, also known as helper T 
(Th) cells, can differentiate into different subtypes, which in turn produce cytokines affecting the 
overall immune response. For example, type 1 helper T (Th1) cells are involved in cell-mediated 
immunity by producing pro-inflammatory cytokines like interferon- (IFN-γ), interleukin (IL-) 2 
and tumor necrosis factor (TNF-) β, which can activate macrophages or CD8+ T cells 23. In 
contrast, type 2 helper T (Th2) cells are characterized by the production of IL-4, IL-5, IL-9, and 
IL-13 and take part in a humoral immune response. In addition to this classical paradigm, CD4+ 
T cells can be polarized depending on the cytokine milieu into for example Th17 cells 
24
, Th3 
cells or transforming growth factor (TGF)-β induced regulatory T cells (Tregs) 
25
. 
After CD8+ T cells received their activating signals from professional APCs in analogy to CD4+ 
T cells 
26
, they turn into cytotoxic T lymphocytes (CTLs) that induce apoptosis of their target 
cells by the tumor necrosis factor  (TNF) member the Fas-ligand or by exocytosis of 
cytoplasmic granule toxins. To the latter belong the membrane-disrupting protein perforin and 
serine proteases, so called granzymes 
27
. For a schematic view on CD8+ T cell mediated cell 
death of target cells see Fig. 1. 
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Fig. 1 Recognition and induced target cell death by a cytotoxic CD8+ T lymphocyte. After 
recognition of the target cell via MHC class I/TCR, an activated, cytotoxic CD8+ T cell (blue) 
mediates target cell (yellow) death by exocytosis of the cytotoxins perforin and granzymes or by 
Fas ligand secretion (adapted to Janeway, Travers, 2001). 
 
1.3.6 T cell-mediated autoimmunity 
If the crucial process of T cell “education” in the thymus (see above) fails and releases self-
reactive T cells that get beyond peripheral control, immunological tolerance is lost, which can 
result in autoimmune diseases. Nowadays, autoimmune diseases are major causes of morbidity 
and mortality and are still difficult or impossible to cure 
28
. The clinical challenge relies in the 
nature of the disease as the cause of the immune response –self antigens – cannot be eliminated. 
The reasons for loss of immunological tolerance are not entirely clear yet but appear to be a 
combination of genetic polymorphisms, acquired environmental triggers and stochastic events. 
Up to now, they have been best described for CD4+ T cells: (1) most well-known became the 
contribution of genetic factors when AIRE was identified as the mutated gene in the autoimmune 
polyendocrine syndrome -1 (APS-1) 
29
. Subsequent studies in AIRE knock-out mouse models 
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revealed that AIRE protein is responsible for the thymic expression of self-antigens that are 
elsewise expressed only in peripheral tissue 
30
. Consequently, the absence of thymic self-antigen 
expression lets T cells escape negative selection with an eventual attack of the body’s own tissue 
31
; (2) Despite the broad self-peptide presentation in the thymus (see above), not all possible self-
antigens may be expressed or may be presented at a level too low to activate T cells 
32
, resulting 
in the release of self-reactive T cells; (3) Although experimental and clinical models fall short in 
explaining the underlying mechanisms of molecular mimicry, at least for MS and type I diabetes 
mellitus it has been hypothesized. There, infectious agents (like viruses) are supposed to share 
antigenic structures with the host’s own tissue resulting in a cross-reactive host’s immune 
response against self-antigens. However, as infections are common and autoimmunity is not, 
further research is necessary to understand the exact pathways 
33
; (4) an imbalance of cytokines 
has been demonstrated in various animal models to be implicated in T cell mediated autoimmune 
pathogenesis 
34
. 
1.4 The pathogenic role of CD8+ T cells in Multiple Sclerosis 
Activated auto-reactive T cells were assumed to play a key role in MS pathogenesis as was 
suggested by the association between MHC class II alleles and MS 
35,36
 as well as findings in 
experimental autoimmune encephalomyelitis (EAE) 
37
. In support, MBP-specific CD4+ T cells 
were shown to contribute to axonal damage when employing organotypic slice cultures of 
murine hippocampus 
38,39
. In MS patients, however, the specific depletion of CD4+ T cells could 
reduce neither the relapse rate nor the inflammatory status 
40
. 
Thus, the almost exclusive focus on CD4+ T cells in MS autoimmune research turned out to be 
oversimplified and too imbalanced. Recently, compelling evidence pointed out the pathogenic 
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importance of auto-aggressive, cytotoxic CD8+ T cells in MS 
41
. For example, histological 
investigations on MS brain tissue revealed that CD8+ T cells outnumber CD4+ T cells within 
demyelinating CNS lesions 
42
 and that they closely interact with demyelinated axons 
43
. 
Furthermore, CD8+ T cells were found clonally expanded in the CSF, in the blood and in CNS 
lesions of MS patients 
42,44
. In addition, CD8+ T cells from MS patients showed a higher 
frequency in CNS-antigen specificity in-vitro when compared to healthy controls 
45
 Finally, 
depletion of CD4+ T cells in MS patients showed no improvement in disease, whereas depletion 
of both CD4+ and CD8+ T cells was beneficial 
46
. 
Experimental set-ups provided functional evidence on CD8+ T cell-mediated lysis of human 
leukocyte antigen (HLA)-matched OLG 
47
 and transsection of dissociated single neurons 
48
. In 
support, in-vivo studies reported CNS injury after injecting myelin-specific CD8+ T cells either 
by using CD8-mediated EAE 
49,50
 or by employing novel approaches, where mice selectively 
express a neo-self antigen in OLG 
51,52
. In both cases, the CD8+ T cell-induced demyelinating 
disease resembled certain pathological features (like upper motor neuron impairment with spastic 
reflexes, ataxia, loss of coordinated movement, perivascular infiltration of CD8+ T cells and 
lesions mostly within the white matter of the cerebellum) observed in MS patients, but which are 
typically absent in myelin-specific CD4+ T cell-mediated EAE 
53
. 
The CNS has long been referred to as an “immune privileged site” that immune cells cannot 
access 
54
, a notion that was reinforced by the anatomical hurdle, the blood-brain barrier (BBB) 
55
. 
However, increasing evidence contradicts this paradigm 
56
 as CNS antigen was detected to drain 
to the cervical lymph nodes (LN) 
57
 and T cells were documented to traffic into the CNS through 
post-capillary venules 
58
. In this context, the individual steps of myelin-specific CD8+ T cell 
activation to cause CNS inflammation and demyelination in-vivo are thought to be the following 
Introduction 
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(in a schematic presentation): in the periphery, myelin-specific CD8+ T cells are activated by 
cross-presenting dendritic cells (for explanation see legend of Fig. 2). After CNS invasion they 
become re-activated by APCs presenting self-antigen to eventually destroy target cells through 
release of their effector molecules (see above). 
 
Fig. 2 Schematic view of myelin-specific CD8+ T cells activation causing CNS 
demyelination. In the lymph node, myelin-specific CD8+ T cells become primed by dendritic 
cells that phagocytosed and processed cell-associated antigens like myelin proteins to present 
them through the MHC class I pathway (referred to as cross-presentation) (1). Primed CD8+ T 
cells migrate to the subarachnoid space by crossing the blood brain barrier (2). In the 
subarachnoid space, T cells are re-activated by macrophages (3), microglia (4) or dendritic cells 
(5) by cross-presentation or they can be directly activated by endothelial cells (6) if these have 
access to myelin e pitopes. CD8+ T cells can then kill target cells by either contact mediated 
Introduction 
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lysis via Fas ligand or by the secretion of soluble mediators like perforin or granzyme eventually 
causing demyelination and axonal loss (7) (adapted to 
59
). 
 
1.5 The importance of myelination 
As highlighted in the clinical signs of MS (see above) or other diseases with compromised 
myelin, such as leukodystrophies in the CNS or peripheral neuropathies in the PNS 
60
, the 
vertebrate nervous system becomes largely non-functional without a proper myelin sheath. The 
importance of myelination becomes further emphasized by its evolutionary conservation. All 
vertebrate classes engulf their axons by myelin membrane wraps of either OLG in the CNS 
61
 or 
Schwann cells in the PNS except for jawless fish, in which axons are surrounded likewise to 
most invertebrates by other glial cell 
62
. 
1.5.1 Structure, function and clinical relevance of myelin 
Myelin is a multi-lamellar sheath of OLG plasma membrane wraps in the CNS that holds two 
major functions: (1) it permits fast, saltatory conduction of the electrical impulse along an axon, 
(2) it appears to be required for axonal trophic support 
63
. To fulfill these functions, myelin has a 
characteristic ultrastructural morphology and biochemical composition. In the CNS, it engulfs 
axons that are larger than 0.2 m in diameter 64 at the internodes that have an average length of 
150-200 m 65. These are separated by spaces lacking myelin, the nodes of Ranvier, which are 
about 1 m in length 66. The nodes of Ranvier show clusters of voltage-dependent Na+ channels 
flanked by fast K
+
 channels in the juxtaparanodal region 
67
. This myelin morphology together 
with its insulating lipid content (myelin contains 70% lipids especially cholesterol and 
glycosphingolipids, 30% proteins and only little water 
68
) ensures fast saltatory impulse 
conduction.  
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Transmission electron microscopy (TEM) studies observed a characteristic lamellar (rather than 
concentric) spiral structure of the myelin sheath with an alternation of light and dark layers 
69
. 
These layers turned out to refer to either the intraperiod line (light layer in TEM, in average 150 
pm thick), in between which the former extracellular space was present, or to the major dense 
line (dark layer in TEM, in average 170 pm thick), the former OLG cytoplasm 
70
. In addition, in 
the myelin sheath areas can be observed that still contain cytoplasm. Based on these findings, 
myelin is divided into compact (no cytoplasm containing) and non-compact (cytoplasm 
containing) myelin that appears not only at different sites but also contains different sets of 
myelin proteins. Non-compact myelin is found at the inner, outer or lateral edges of the OLG 
membranes, the so called inner or outer loop or respectively the paranodal loops at the node of 
Ranvier (Fig. 3). 
 
Fig. 3 Myelin nomenclature. As depicted, cytoplasm containing non-compact myelin is found 
at ad- and ab-axonal sites, referred to as inner and outer loop respectively and at the lateral edges 
of myelin at the unmyelinated nodes of Ranvier, the lateral loops (adapted to 
71
). 
An extended view on myelin in terms of its biochemical composition, myelin compaction and 
axonal integrity was obtained from rather rare non-inflammatory, genetic alterations in myelin 
proteins or lipids. 
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For example, mice expressing a mutant myelin basic protein (MBP; the MBP isoforms account 
for ~ 30% of the myelin proteins) with the shiverer (shi) mutation suffer from generalized 
intention tremors, convulsion and die a premature death within 50-100 days after birth. 
Ultrastructural analysis revealed CNS dysmyelination in these mice with tightly compacted 
myelin at the intraperiod lines but no major dense lines 
72
. MBPs suspected role in compaction 
was confirmed when shi/shi mice were rescued after being crossed with transgenic MBP 
expressing mice 
73
. 
Furthermore, mice carrying the X-chromosomal jimpy (jp) mutation in proteolipid protein (PLP; 
PLP is the major myelin protein in the CNS, accounting with its splice variant DM-20 for ~50% 
of the myelin proteins 
74
) show axial body tremors, tonic seizures and also die a premature death 
75
. Here, TEM analyses revealed intact major dense lines but severe alterations of the intraperiod 
line 
76
. Accordingly, PLP was suggested to function as a molecular “zipper” by linking apposing 
membranes to form compact CNS myelin 
77
. In addition, PLP appears to be essential for the 
enrichment of cholesterol, the major lipid of myelin 
78
. Mutations in the PLP gene also account 
for rare human diseases, such as the recessive, X-linked Pelziaeus-Merzbacher disease (PMD) 
79
, 
where male patients show ataxia and myoclonic seizures and die shortly after birth. 
Besides of the functions of some of these classical myelin proteins, others were only recently 
identified. For example, in a microarray analysis of healthy versus demyelinated mouse brain the 
OLG-specific actin binding protein Ermin was found. As a non-compact myelin protein it was 
suggested to cross-link membrane proteins with the OLG cytoskeleton and to interact with Rho 
GTPases to regulate the OLG cytoskeleton 
80
. In addition, CNS myelin contains distinctive radial 
components 
81
, built by the tight junction proteins claudin/OSP 
82-84
. Recently, one of the few 
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known axonal-glial interaction partners were identified, formed by a complex of Caspr/paranodin 
and contactin on the axonal side with neurofascin 155 on the glial membrane 
85-87
. 
1.6 The current concept how myelination is achieved 
Despite a fairly detailed knowledge why myelin’s proper wrapping and composition is 
important, only little is known about the wrapping mechanism per se. In light of the fact that at 
least in the CNS the OLG cell body cannot move to form multilamellar myelin, the assembly of 
the membranes could formally be achieved by: (1) an active process of the myelinating cell, 
where the axon remains comparatively passive, (2) an active myelin membrane pulling by the 
axon, where the myelinating cell remains comparatively passive or (3) a mixture of both. 
Surprisingly, the present myelination theories favor the first possibility and neglect the others. 
The currently most accepted sequence of events for myelination is 
88
: (1) an OLG process curls a 
membrane sheath around an axon, (2) after this sheath completed its first turn, the growing 
membrane advances itself under the already existing membrane wrap as it was crawling 
underneath a carpet. (3) This procedure of spiral wrapping continues until the final myelin 
thickness is achieved. (4) The process is accomplished by an unknown mechanism leading to the 
extrusion of cytoplasm to allow the close apposition of membranes to form compact myelin. (5) 
The final myelin product would resemble a rolled up carpet with a smooth surface resulting in a 
parallel run of inner and outer loop (hereafter referred to as “carpet crawler” model; Fig. 4). 
However, not even a single study up to this date provided satisfying evidence for any of these 
events. It is thus not surprising that this too simplified model has repeatedly been questioned by 
other studies (see below). 
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Historically, Geren et al. suggested in their earliest TEM study that myelin develops by an 
infolding process of the Schwann cell surface based on their observations of chick embryo sciatic 
nerve 
89
. A little later, Luse et al. proposed for the CNS that the myelin sheath forms by the 
joining of membranes from different glial processes as a patchwork quilt of plasma membranes 
90
. Others in turn assumed that myelin derives from membranous segments synthesized in the 
glial cytoplasm, which eventually fuse to from the myelin sheath 
91
. In the style of the 
mechanism for peripheral myelinogenesis, Peters et al. suggested an advancement of the glial 
inner process in the fashion of spiral wrapping, where compact myelin arises by the loss of 
cytoplasm 
92
, which was supported by others 
93
. Later, this theory, to which we will refer to as 
the “carpet crawler” theory, was claimed to be proven by an in-vitro live imaging study of 
myelination. The observation that the Schwann cell nucleus moved around the co-cultured axon 
during myelination let the authors conclude that this nuclear rotation reflected the movement of 
the inner glial process to form myelin 
88
. However, this “proof” cannot explain CNS myelination, 
since the OLG cell body has to remain stable when myelinating up to 50 or more different axons.  
1.7 The current myelination concept in question 
Although each of the studies is rather incomplete as all used either fixed tissue for TEM analysis 
at a single level or in-vitro co-culture models, the latter hypothesis prevailed, even despite 
questioning consecutive studies (see below) that used more sophisticated approaches.  
For example, Webster et al. performed a three dimensional TEM reconstruction from serial 
sections to obtain a more complete picture of the myelin sheath. As a result, he described an 
uneven growth of the myelin membranes at different levels of the same internode 
94
. This uneven 
growth, reflected in an inhomogeneous contour of myelin caused most likely by a maximum 
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thickness near the middle of the internode, was also confirmed by others 
95,96
. Further TEM 
studies noted myelin formations with cytoplasmic inclusions, which could not easily be 
explained by the established concept and thus asked for a more complex explanation 
71
. Later, 
light microscopic studies showed the spiraling of the ostensibly outer tongue or respectively, the 
distribution of caspr in a helical coil along the internode 
80,82,84,97-99
. That the findings are artifacts 
or that they are confined to only developing myelin is rather unlikely, as a continuous myelin 
sheath turnover in the adult CNS was suggested 
100
. Since the “carpet crawler” hypothesis, where 
the myelin outer tongue runs in parallel with the long axis of the axon, cannot explain such 
features, an alternative myelination model was suggested. There, a myelin ribbon coils 
unidirectional around the axon like a serpent around a tree, followed by a lateral outgrowth of the 
ribbon (hereafter referred to as “serpent” model; Fig. 4) 98. By this lateral myelin outgrowth, the 
outer loop runs in a coil along the internode resembling a bandage wrapped up for a cast. 
 
Fig. 4 Current views on myelin wrapping. An OLG process comes in close contact with an 
axon (A). According to the “carpet crawler” hypothesis (B and C) the growing membrane 
advances itself under the already existing membrane wrap until the final myelin thickness is 
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achieved. In contrast, the “serpent” model (D, E, F) suggests an unidirectional coiling of a 
myelin ribbon around the axon (adapted to 
101
). 
 
It is peculiar that both models assume myelination to be an active process of the myelinating cell, 
where the axon remains comparatively passive, especially as increasing evidence underlines an 
axonal contribution Besides, high energy expenditure due to friction caused by the advancement 
of the inner myelin tongue with constant adhesion and loosening questions the “carpet crawler” 
model. Likewise, the “serpent” model neither explains the feature of paranodal loops, where the 
most outer myelin layer is the closest to the node of Ranvier, nor maximum thickness of myelin 
at the middle of the internode. 
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2 Rationale 
As described above, CD8+ T cells are increasingly believed to participate in the pathophysiology 
of MS 
41,43
 but the underlying mechanisms have remained unclear. Particularly, in the past 
neither of the studies addressed the pathogenic role of myelin-reactive CD8+ T cells with regard 
to axonal damage. To clarify whether myelin-reactive, cytotoxic CD8+ T cells directly attack 
axons or whether axonal loss may be the result of a targeted hit against myelinated structures 
indicating “collateral bystander damage”, we established a novel experimental system of 
inflammatory CNS injury: 
Auto-aggressive, cytotoxic ovalbumin (OVA)-TCR CD8+ T cells (OT-I T cells) were traced in 
real time by continuous confocal imaging in living PLP-GFP (see later) derived cerebellar brain 
slices 
102
. In an inflammatory environment, we either loaded brain tissue with the cognate OT-I T 
cell antigen, the peptide SIINFEKL, or we restricted OVA expression exclusively to the cytosol 
of OLG by crossing PLP-GFP mice with transgenic mice where OVA is sequestered to OLG 
(ODC-OVA mouse 
103
). Live imaging and subsequent morphological analysis let us demonstrate 
that axonal loss can be the consequence of “collateral bystander damage”, resulting from a CD8-
mediated attack directed against the cognate antigen processed and presented by OLG. 
On the basis of the controversy on myelin formation presented above, the cellular mechanisms of 
CNS myelination remain an interesting and challenging problem. To clarify myelin formation in 
the CNS, we performed a comprehensive high-resolution live imaging, light and electron 
microscopy study in organotypic cerebellar slice cultures (OCS), young and adult CNS derived 
from transgenic PLP-GFP mice, which carry a fusion-protein of the first 13 transmembrane 
amino acids of proteolipid protein (PLP) with green fluorescent protein (GFP) 
102
 (and B. Zalc, 
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personal communication). Our results show clearly an evenly spaced, bi-directional coiling of the 
myelin outer loop that developed during myelin formation and that was present in both young 
and adult mice. Based on our observations and supporting evidence discussed below, we 
proposed a new myelination hypothesis, the “liquid croissant” model”. Our concept resolves not 
only the current, most suspected concerns and explains previous observation but it attributes a 
yet unaddressed function to the axon, which may help to explain myelination deficits during 
remyelination or axonopathies. 
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3 Materials and Methods 
Mice. Mice (all C57BL/6 background) were bred at the animal facilities of the University of 
Zurich under specific pathogen-free conditions, and all experimental procedures were approved 
by the Swiss Veterinary Office (121/2009). OT-I and OT-II mice carrying a transgenic T cell 
receptor (TCR) specific for ovalbumin (OVA) amino acids 257-264 (SIINFEKL) in H-2K
b
 or for 
OVA323-339 in H-2IA
b
, respectively, were obtained from The Jackson Laboratory (USA). 2D2 
transgenic mice carrying CD4+ T cells with a TCR reactive for MOG35-55 were kindly provided 
by V. Kuchroo (Boston, USA) and ODC-OVA (oligodendrocyte-ovalbumin) transgenic mice 
were obtained from T. Hünig (Würzburg, Germany) and were genotyped as defined elsewhere 
103
. PLP-GFP transgenic mice were a kind gift from B. Zalc (Paris, France). The original PLP-
LacZ mouse 
104
 was described to show a similar expression pattern of the PLP-LacZ fusion 
protein when compared to endogenous PLP. It was modified subsequently 
102
 by replacing LacZ 
with EGFP to generate the PLP-GFP mouse (B. Zalc personal communication) which carries a 
PLP-EGFP fusion protein. 
Genotyping. A small biopsy of mouse tail dissolved in tail lysis buffer (100 mM Tris/HCl pH 
7.5, 1M Tris pH 7.5, 5 mM EDTA, 0.5M EDTA, 0.2% (w/v) SDS, 200 mM NaCl, 10mg/ml 
proteinase K) at 55 °C for 4 h. After precipitation in isopropanol and washing with 70 % ethanol 
samples were diluted in TE buffer and stored at -20 °C. Genotyping of PLP-GFP mice was 
performed using the following primers: for PLP-GFP forward 5’-CAA AAC AGC TGT CTG 
TAT ATC ATG CTT GC-3’; PLP-GFP reverse 5’-GTG GAT GAG TTA CCT CGT ATG CGT 
ACC-3’ with an annealing temperature at 57 °C; primers for the other mice described above are 
defined in the respective references. 
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Organotypic cerebellar slice culture. To study (patho)physiological processes in the CNS, we 
obtained organotypic cerebellar slice cultures (OCS) from 8 to 10-day-old mice, in which the 
brain parenchyma is preserved in a proper network organization ex-vivo 
105
. After decapitation 
the cerebellum was removed and put into ice-cold dissecting medium (HBSS (Invitrogen, Basel, 
Switzerland) supplemented with penicillin/streptomycin (Invitrogen; 100 U/ml and 100 g/ml 
respectively), 2.5 mg/ml glucose and 10 mM kynurenic acid (both by Sigma, Buchs, 
Switzerland). It was then cut with a McIllwain tissue chopper (GaLa Instruments, Bad 
Schwalbach, Germany) into 400-500 m thick cerebellar slices. OCS were cultured on Millicell 
plate inserts, pore size 0.4 mm (Millipore, Zug, Switzerland) according to Stoppini et al. 
106
 in 
culture medium (50 % (v/v) MEM, 25 % (v/v) HBSS, 25 % (v/v) heat-inactivated horse serum, 
supplemented with penicillin/streptomycin (100 U/ml and 100 g/ml respectively), 2 mM L-
glutamine (all from Invitrogen) and 2.5 mg/ml glucose (Sigma). OSC were incubated at 36 °C in 
a humidified atmosphere with 5% CO2 for at least 7 days to allow tissue flattening 
105
. Where 
indicated, slice culture medium was supplemented with 100 U/ml IFN (Preprotech, USA) 72 h 
prior to co-culture experiments.
Activation and enrichment of T cells. Splenocytes were obtained from euthanized OT-I, OT-II 
and 2D2 mice and were cultured in RPMI supplemented with 10 % (v/v) heat-inactivated foetal 
calf serum, penicillin/streptomycin (100 U/ml and 100 g/ml respectively) and 5 mM L-
glutamine (all by Invitrogen). OT-I cells were stimulated with their cognate antigen SIINFEKL 
peptide or Smcy738-746 (H-Y) control peptide (5 g/ml, GenScript Corp., USA). OT-II and 2D2 
splenocytes were incubated with their cognate antigen Ovalbumin323-339 peptide or MOG35-55 
peptide (both 5 g/ml, GenScript Corp.), respectively. Splenocytes were kept for 24 h in culture 
medium only for non-activation or were incubated with anti-CD3 antibody (5 g/ml, Bioexpress, 
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USA) for unspecific stimulation. Supernatants were analysed for IFN production and T cells 
were enriched by negative selection according to the manufacturer's instructions (Mouse CD8 or 
respectively CD4 T Lymphocyte Enrichment Set by BD Biosciences, USA). Enriched T cell 
populations were labelled with the infrared DiD lipophilic tracer (Invitrogen) according to 
manufacturer's instructions. 24 h prior to time lapse imaging, T cells were applied on cerebellar 
slices (1x10
6
 cells/slice), placed on ibiTreat chambers (ibidi, Germany) to allow T cell tissue 
invasion. 
CNS tissue preparation for cryostat sections. Mice were perfused with 4 % (w/v) freshly 
prepared paraformaldehyde (PFA; Sigma) in 0.1 M phosphate buffer, pH 7.4 at room 
temperature (RT) with 200 ml/mouse within 15 min and CNS tissue was post-fixed for 48 h in 
4% PFA after removal. Tissue was then equilibrated with 30 % sucrose and was frozen with 
Tissue-Tek (Qiagen, Hombrechtikon, Switzerland) in isopropanol cooled to – 40 °C. Tissue was 
cut with a cryostat into 40 m thick for free floating sections. 
Confocal time lapse imaging. For confocal live imaging, slices were placed on ibiTreat 
chambers (ibidi, Munich, Germany). Myelin and T cells in slices were visualized by an SP5 
Leica motorized confocal laser scanning microscope (SP5; Leica, Heerbrugg, Switzerland) using 
an Argon laser with a 20 x objective (oil immersion, numerical aperture (NA) 0.7, Leica) or a 63 
x objective (glycerol immersion, numerical aperture (NA) 1.3, Leica) as indicated. Slices were 
maintained in an incubation chamber at 36 °C using a heated stage and 36
 
°C warm slice culture 
medium was equilibrated with 95% O2 and 5% CO2. Three dimensional datasets were acquired 
every 5-45 min over periods as indicated. 
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Immunostaining. OCS were fixated in 4 % (w/v) formaldehyde for 2 h at RT and were 
permeabilized in 1 % (v/v) Triton X-100 (both in PBS; both by Sigma). After three washes in 
PBS, OCS were blocked for 1 h at RT with 10 % (v/v) normal goat serum (Invitrogen) in 0.2 % 
(v/v) Triton X-100 in PBS. Primary antibodies were diluted in 1 % (v/v) goat serum in 0.2 % 
(v/v) Triton X-100 in PBS and were incubated with OCS for 3 days at 4 °C. After three washes 
in PBS, secondary antibodies diluted in 1% (v/v) goat serum in 0.2 % (v/v) Triton X-100 in PBS 
were added overnight at 4 °C. After three washes in PBS, OCS were mounted on glass slides. 
Antibodies. For primary antibodies monoclonal mouse anti-murine neurofilament 200 antibody 
(clone N52; Sigma-Aldrich, Buchs, Switzerland), monoclonal mouse anti-murine MOG (ms8-
18c5 hybridoma, kindly provided by C. Linnigton, Glasgow, UK), monoclonal rat anti-murine 
MBP (Serotec, Dusseldorf, Germany), polyclonal rabbit anti-murine PLP (Abcam, Cambridge, 
UK), polyclonal rabbit anti-murine paranodin (kindly provided by J.-A. Girault, Paris, France), 
monoclonal rat anti-murine MHC class I (clone ER-HR52, BMA Biomedicals, Switzerland) or 
monoclonal rat anti-murine MHC class II (clone M5/114.15.2, BD, UK) were used as indicated 
and were detected with secondary goat anti-mouse Alexa Fluor 405-conjugated antibody, goat 
anti-rabbit Alexa Fluor 546-conjugated antibody or goat anti-rat Alexa Fluor 594 or 633-
conjugated antibody (all by Invitrogen). 
Laser scanning confocal microscopy, image analysis and video processing. Confocal 
microscopy from fixed and immunostained slices was performed using an SP2 or SP5 confocal 
laser microscopes (Leica) with 10 x (dry, NA 0.5), 20 x (glycerol immersion, NA 0.7) or 63 x 
(glycerol immersion, NA 1.3) objectives. Image series from fixed and stained slices and 
sequences from time lapse imaging including z-stacks were collected in an optimized manner (z 
steps 0.13 m) to allow subsequent deconvolution using Huygens deconvolution software SVI 
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(distributed by Image Solutions, Preston, UK). Images were analysed using Imaris software 
(version 7.1, Bitplane, Zurich, Switzerland) and videos were processed using Adobe After Effect 
(version CS4; Adobe, San Jose, USA) or FinalCutPro (version 6.01, Apple, USA). 
High pressure freezing, transmission and scanning electron microscopy (TEM and SEM). 
OCS were high-pressure frozen using a Leica EM HPM100 high-pressure freezing machine 
(Leica Microsystems, Vienna, Austria). For that, the whole cerebellar slice including culture 
membrane was excised with a 4 mm biopsy punch (Kai Medical Nr. BPP-40F, Poymed Medical 
Center, Glattbrugg, Switzerland) on a Teflon surface and was transferred into a 6 mm aluminium 
specimen carrier with an indentation of 5 mm x 0.1 mm. Excessive medium was drawn off with 
a filter paper and the head space was filled with 1-hexadecene (Sigma-Aldrich). The sandwich 
was completed with a flat 6 mm aluminium specimen carrier and moved to the recess in the 
middle plate of the cartridge to be immediately high-pressure frozen. Frozen specimens were 
freeze-substituted in anhydrous acetone containing 2 % OsO4 in a Leica EM AFS2 freeze-
substitution unit (Leica Microsystems). Specimens were kept successively at -90 °C, -60 °C, and 
at -30 °C for 8 h each. Temperatures were changed at a rate of 30 °C per hour, finally reaching 0 
°C. After keeping the specimens at 0 °C for 1 h, OsO4 was removed by washing the specimens 
with anhydrous acetone twice. For transmission electron microscopy, specimens were gradually 
embedded in Epon/Araldite (Sigma-Aldrich) 33% in anhydrous acetone overnight at 4°C, 66% in 
anhydrous acetone for 6 h at 4°C and 100% for 1h at room temperature prior to polymerization at 
60°C for 48 h. Ultrathin sections were stained with aqueous uranyl acetate 2 % and Reynolds 
lead citrate and imaged with a Phillips CM 100 transmission electron microscope (FEI, 
Eindhoven, Netherlands) using a Gatan Orius CCD camera and digital micrograph acquisition 
software (Gatan GmbH, Munich, Germany). For scanning electron microscopy, specimens were 
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critically point dried in a CPD 030 (Leica Microsystems). Tissue pieces were removed from the 
filter, fractured and mounted on SEM stubs with conductive carbon with the fractured cross-
section facing upwards. Samples were sputtered with 4 nm of platinum or gold/palladium in a 
SCD 500 sputter coater (Leica Microsystems) and imaged in a Zeiss Supra 50 VP scanning 
electron microscope (Gloor Instruments, Uster, Switzerland) at 10 kV using the in lens 
secondary electron detector. 
3D myelin modelling. 3D myelin was modelled using Strata 3D software (version 5.5.1, 
Macromedia, Santa Clara, USA). 
Statistical analysis. Data were obtained from at least three independent experiments performed 
in duplicate or triplicate. Results were expressed as means ± standard error of the mean (S.E.M.). 
Statistical significance of mean differences was assessed by one-way ANOVA followed by 
Bonferroni post-test using GraphPad Prism software (version 4.02, San Diego, USA). 
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4 Results 
4.1 Axonal loss by myelin-directed CD8+ T cells 
In order to investigate if auto-aggressive, cytotoxic CD8+ T cells can potentially cause axonal 
loss by “collateral bystander damage”, we established confocal live imaging in a model system 
of CNS inflammation.  
 IFN up-regulates MHC class I expression on myelin
To obtain an inflammatory environment, living brain slices were pre-incubated with the pro-
inflammatory cytokine IFN, described to enhance MHC expression. Subsequent confocal 
microscopic analysis of fixed slices, stained for neurofilament (NF) and either MHC class I or 
MHC class II molecules, demonstrated that both MHC class molecules were differentially 
inducible upon treatment with IFN (Fig. 5). As expected, MHC class II was neither observed on 
myelin nor axons but on microglia (Fig. 5B), whereas MHC class I expression was most 
pronouncedly identified on myelin (Fig. 5C and subset of C). As such, IFN-induced up-
regulation of MHC class I molecules ensured the key prerequisite for antigen presentation to and 
recognition by CD8+ T cells 
107
. 
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Fig. 5 Incubation with IFN induces MHC class I and II expression. Confocal images of co-
stained MHC class I and II (red) and NF (cyan) reveal only marginal MHC expression in 
untreated ODC-OVA x PLP-GFP brain slices (A). Yet, presence of IFN (100 U/ml, 72h) 
induces MHC expression (B, C). Whereas MHC class II was most likely observed on microglia 
(B), MHC class I was mainly induced on OLG (C and lower panel of C). Scale bars equal 20 m 
in (A, B and C) and 7.5 m for lower panel in (C). 
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4.1.2 CD8 + T cells cause myelin damage in SIINFEKL pulsed OCS 
To assess the impact of cytotoxic CD8+ T cells on axonal injury, we pulsed IFN pre-treated 
brain slices from PLP-GFP mice with ovalbumin (OVA) peptide257-264 (SIINFEKL). Addition of 
SIINFEKL pre-stimulated CD8+ OT-I T cells (Fig. 6 B, D) resulted in direct injury of 
myelinated fibers (Fig. 7B). In contrast, application of CD4+ OT-II T cells onto PLP-GFP brain 
slices loaded with MHC class II OVA peptide323-339 (Fig. 6A, C) left myelin and axons intact in 
the previously described experimental set-up (Fig. 7A). 
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Fig. 6 Antigen-specific stimulation results in specific activation of T cells. Flow cytometric 
stains show the ratio of CD4+ compared to CD8+ T cells in OT-II (A) and OT-I (B) whole 
splenocytes. Whole splenocytes from either OT-II (C) or OT-I (D) mice were stimulated for 24 h 
as indicated and supernatants were subjected to quantitative IFN ELISA (C, D) displaying 
significantly increased IFNg secretion of CD8+ OT-I T cells when incubated with cognate 
peptide (SIINFEKL). Note, that OT-I splenocytes contain mostly CD8+ T cells (B), while OT-II 
splenocytes contain both CD4+ and CD8+ T cells (A), which may account for the differences in 
IFNg secretion when stimulated with cognate peptide vs. anti-CD3 antibody (C, D). Nd= non-
detectable; values are  mean S.E.M., n=3, for p-value generation one-way ANOVA followed by 
Bonferroni post test was used to compare among groups. 
 
 
Fig. 7 SIINFEKL pre-stimulated CD8+ OT-I T cells cause myelin damage in SIINFEKL 
pulsed PLP-GFP brain slices. PLP-GFP brain slices, pre-treated with IFN and pulsed with 
OVA peptide323-339 (A) or SIINFEKL (B) peptide were incubated with OVA peptide323-339 
pre-stimulated CD4+ OT-II T cells (A) or SIINFEKL pre-stimulated CD8+ OT-I T cells (B). 
Whereas no change in myelin morphology is observed when adding OVA peptide323-339 pre-
stimulated CD4+ OT-II T cells (A), SIINFEKL pre-stimulated CD8+ OT-I T cells closely 
interact and damage myelin (B). In the upper left corner time elapsed after start of the respective 
sequence is documented, scale bars equal 15 m. 
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4.1.3 CD8+ T cells cause axonal loss even when the antigen is restricted to OLG 
Although we observed CD8-mediated axonal damage in peptide-pulsed brain slices, in which we 
could not detect MHC class I expression by axons, we could not formally exclude the possibility 
that the peptides loaded onto the brain slices were presented by axons. To specifically address 
the question whether axonal loss is the result of a direct T cell-axon recognition or driven 
primarily by an attack against the myelin sheath, we restricted the cognate T cell antigen 
expression to OLG. We therefore refined our system by crossing PLP-GFP mice with transgenic 
mice expressing OVA in the cytosol of OLG only (ODC-OVA x PLP-GFP mice). 
SIINFEKL or anti-CD3 antibody (data not shown) pre-stimulated CD8+ OT-I T cells directly 
attacked and transected myelinated axons in ODC-OVA x PLP-GFP brain slices, causing 
extensive tissue injury (Fig. 8C, D). Yet, the observed pathology was neither detected when 
applying (i) non-activated (Fig. 8A), nor (ii) control peptide pre-stimulated CD8+ OT-I T cells 
(Fig. 8B), nor when adding (iii) adequately pre-stimulated CD8+ OT-I cells to ODC-OVA 
negative slices (data not shown) or (iv) ODC-OVA positive slices not pre-exposed to IFN (data 
not shown). 
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Fig. 8 Direct transsection of myelinated axons by CD8+ OT-I T cells. Frames from confocal 
time lapse sequences were captured and document only little invasion of non-activated (A) or 
control peptide (B) pre-stimulated CD8+ OT-I T cells (red) into ODC-OVA x PLP-GFP brain 
slices. Myelin damage was not observed in either situation (A, B). Contrarily, SIINFEKL pre-
stimulated CD8+ OT-I T cells entered brain slices to great extent (C) and directly attacked 
myelin (green) (subregion of (C)). Additionally, pronounced blebbing of OLG after T cell attack 
was observed (D). In the upper left corner time elapsed after start of sequence is documented, 
scale bars equal 30 m in (A, B and C) and 10 m for sub-region of (C) and in (D). 
 
Equally, loading of IFN pre-treated PLP-GFP brain slices with whole ovalbumin protein did not 
cause OT-I-mediated CNS injury (Fig. 9). 
 
Fig. 9 SIINFEKL pre-stimulated CD8+ OT-I T cells do not cause myelin damage when 
pulsing PLP-GFP brain slices with complete ovalbumin protein. Immunostaining for 
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neurofilament (cyan) and myelin basic protein (MBP; red) reveals that SIINFEKL pre-stimulated 
CD8+ OT-I T cells leave myelin and axons intact in PLP-GFP brain slices pulsed with complete 
ovalbumin protein (lower panel). In contrast, myelin and axons are extensively damaged by 
SIINFEKL pre-stimulated CD8+ OT-I T cells in ODC-OVA x PLP-GFP brain slices (upper 
panel). Scale bar represents 150 m. 
 
In addition, both CD4+ OT-II and 2D2 T cells left myelin and axons intact in IFN pre-treated 
ODC-OVA x PLP-GFP brain slices (Fig. 10). 
 
Fig. 10 CD4+ OT-II and 2D2 T cells leave myelin and axons intact in ODC-OVA x PLP-
GFP brain slices. (A) Frames from confocal-time lapse sequences were captured displaying 
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myelin in green and differentially pre-stimulated OT-II T cells in red as indicated. No alteration 
of myelin morphology can be observed in either situation (A-C). (B) Immunostaining for 
neurofilament (cyan) and myelin basic protein (MBP; red) from fixed ODC-OVA x PLP-GFP 
brain slices show no alteration in axonal and myelin morphology after incubation with 
differentially pre-stimulated 2D2 T cells as indicated. In the upper left corner time elapsed after 
start of the respective sequence is documented, scale bars represent 30 m in (A) and 50 m in 
(B). 
 
Injury of myelinated axons appeared to correlate directly with CD8+ T cell migration into and 
interaction with the brain parenchyma. Spot analysis from z-stacks of confocal time lapse 
imaging underscored that SIINFEKL peptide pre-stimulated OT-I T cells invaded IFN pre-
treated ODC-OVA x PLP-GFP brain slices to significantly greater extent than did non-activated 
or control peptide pre-stimulated OT-I T cells (Fig. 12). Additionally, longer lasting interactions 
of SIINFEKL pre-stimulated OT-I T cells with CNS tissue were observed when compared to 
non-activated and control peptide pre-stimulated T cells. In line, trajectory analysis revealed a 
“scanning” behavior of SIINFEKL pre-stimulated OT-I T cells whereas non-activated or control 
peptide pre-stimulated T cells displayed a “straight forward” motion (Fig. 11), similarly to that 
behavior described for CD4+ T cells 
108
. As such, CD8-mediated CNS injury appeared to depend 
both on the T cell activation status and the cognate antigen being presented by MHC class I 
expressing OLG. 
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Fig. 11 Heterogenous migration behavior of CD8+ OT-I T cells. Analysis of time lapse 
imaging of CD8+ OT-I T cells on ODC-OVA x PLP-GFP slices shows that CD8+ OT-I T cell 
migration is variable in direction and distance as depicted in tracings of migratory paths (A, non-
activated; B, control peptide pre-stimulated; C, SIINFEKL pre-stimulated). Trajectories, shown 
for an elapsed time of 16 h, also illustrate mobile and immobile CD8+ OT-I T cell behavior, as 
well as transition between the two modes. 
 
Subsequent morphological analysis of ODC-OVA x PLP-GFP brain slices exposed to 
SIINFEKL peptide pre-stimulated OT-I T cells revealed widespread, patchy disintegration of 
axonal morphology (Fig. 12A and B). Quantification of axonal injury confirmed significantly 
more axonal loss in ODC-OVA x PLP-GFP brain slices exposed to SIINFEKL peptide pre-
stimulated OT-I T cells when compared to controls (Fig. 12D). 
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Fig. 12 SIINFEKL pre-stimulated cytotoxic OT-I T cells invade brain tissue and cause 
damage of myelinated axons. Spot analysis from confocal time lapse imaging revealed that 
SIINFEKL pre-stimulated CD8+ OT-I T cells invaded ODC-OVA x PLP-GFP slices to a 
significantly greater extent than non-activated or control peptide pre-stimulated CD8+ OT-I T 
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cells (C). Extensive disruption and irregularities of both myelin (green) and axons (cyan) in 
ODC-OVA x PLP-GFP brain slices were observed after incubation with SIINFEKL pre-
stimulated CD8+ OT-I T cells (A) in contrast to well-maintained structures in slices incubated 
with non-activated CD8+ OT-I T cells (B). Quantification of axonal damage confirms that 
neurofilament was significantly injured in ODC-OVA x PLP-GFP brain slices incubated with 
SIINFEKL pre-stimulated CD8+ OT-I T cells when compared to controls (D). Results are 
expressed as percentage of intact neurofilament compared to ODC-OVA x PLP-GFP brain slices 
incubated with non-activated CD8+ OT-I T cells. Values are  mean S.E.M., n=3, for p-value 
generation one-way ANOVA followed by Bonferroni posttest was used to compare among 
groups (C, D). Scale bars equal 200 m in (A, B). 
 
As expected, the CD8+ T cell release of cytotoxins like perforin appeared to participate in the 
damage of myelinated axons suggested by the polarized location of perforin towards the 
myelinated axon (Fig. 13). 
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Fig. 13 OT-I T cells polarized perforin towards myelinated axons. OCS incubated with OT-I 
T cells (red) were fixated and stained for Neurofilament (cyan) and perforin (purple). Confocal 
analysis revealed that perforin granules were polarized towards myelin (green) surrounding an 
axon (cyan), best observed in the section view displaying the z-plane. Scale bars equal 5 m. 
 
In conclusion, we could show in our experimental system, in which the cognate antigen was 
sequestered to oligodendrocytes exclusively, that oligodendrocytes are capable of processing and 
presenting antigen to auto-aggressive, cytotoxic CD8+ T cells. In turn, CD8+ T cells directly 
targeting the myelin sheath cause axonal loss due to “collateral bystander damage”. 
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4.2 Myelin formation in the CNS 
To examine myelination in the CNS, we performed high-resolution live imaging, light and 
electron microscopy study in organotypic cerebellar slice cultures (OCS), young and adult mouse 
CNS. As a model system for myelin live observation, we used OCS derived from transgenic 
PLP-GFP mice 
102
. In these mice, a fusion-protein of the first 13 transmembrane amino acids of 
proteolipid protein (PLP) with green fluorescent protein (GFP) is expressed under the PLP 
promoter and has previously been described to show a similar localization to endogenous PLP 
104
. 
4.2.1 Myelin runs in a bi-directional coiled turn along the internode 
We first verified the suitability of PLP-GFP mice derived OCS to ensure that the observed PLP-
GFP could indeed reflect myelin formation. A comparison of PLP-GFP with endogenous PLP by 
means of colocalization analysis revealed a similar expression pattern as described previously
104
, 
allowing the visualization of both myelin and mature oligodendrocytes (Fig. 14a, b). We further 
confirmed intact CNS morphology in OCS by light and electron microscopy which resembled in-
vivo CNS tissue, thus validating OCS as a proper model system (Fig. 14c, d). 
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Fig. 14 Slice cultures derived from PLP-GFP mice appear suited as a model system to study 
myelination. (a) Fixed OCS derived from PLP-GFP (green) mice were stained with PLP (red) 
and NF (cyan). (b) Comparison of endogenous PLP with PLP-GFP show a similar distribution 
around the axon, confirmed by the white fluorescence representing colocalization. For 
colocalization analysis serial optical sections were acquired in an optimized manner to calculate 
Pearson coefficients after deconvolution analysis. Morphologically intact CNS tissue in OCS 
was found both by (c) paranodin staining (red) implying proper nodes of Ranvier and (d) 
ultrastructural TEM analysis. Scale bars equal 3 m in (a, b), 20 m in (c) and 1 m in (d). 
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High-resolution confocal imaging in OCS was superior to multi-photon imaging (data not 
shown) and displayed coiled turning of myelin (Fig. 15a) that typically, but not exclusively ran 
bi-directionally along the internode as seen in the slice view (Fig. 15b) resembling the bi-
directionally spiralling dough edges of a croissant. 3D surface rendering verified the coiled 
turning and visualized, as expected, not a smooth but uneven myelin surface (Fig. 15b). 
Interestingly, the coiled myelin turns showed regular interspaces of 5.2 m in average length 
(Fig. 15c). Ultra-structural analysis of OCS let us notice uncompact, outer myelin membrane 
layers, the myelin outer loop, that displayed helical turns along the internode, thus most likely 
accounting for the light microscopic observation of myelin helical turning (Fig. 15d, e). 
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Fig. 15 Coiled turning of myelin observed in light microscopy is evoked by the myelin outer 
loop. (a, b) Confocal microscopic analysis of PLP-GFP (white) shows (a) coiled myelin with (c) 
similar spacing along the internode (arrows in a). Myelin coiling typically, but not exclusively 
ran (b) bi-directional as seen in the slice view (arrows). 3D surface rendering verified the coiled 
turning and visualized, as expected, not a smooth but uneven myelin surface. Transmission (d) 
and scanning (e, f) electron microscopy revealed turning of the cytoplasma containing outer 
loop. Scale bars equal in (a, b) 3 μm, in (c, d) 500 nm and in (e) 200 nm. 
 
Likewise, we detected coiled myelin turns with similar characteristics in perfusion-fixed young 
and adult PLP-GFP (Fig. 16) and wildtype mice (not shown). This excluded not only any OCS or 
PLP-GFP related artefacts but demonstrated that the coiled turns of myelin represent the overall 
myelin structure in various regions in the CNS irrespective of the developmental stage. 
 
Fig. 16 Similar myelin helix formation is found in different brain regions of young and 
adult mice. Confocal microscopic tile scans of perfusion fixed adult (a) and young (b) PLP-GFP 
(green) mouse brains that were stitched and analyzed for MOG (red, in a) or MBP (red, in b). 
Even in the adult mouse, different brain regions reveal myelin turns similar to these found in 
OCS. HC = Hippocampus, CB = Cerebellum; scale bars equal in (a), (b) 1000 μm and for inserts 
2 μm. 
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4.2.2 The myelin helix forms during myelin outgrowth and is highly motile 
To profit from the moving image in understanding how the final myelin product is formed, we 
initially performed coarse time-lapse imaging and could observe myelin outgrowth in OCS over 
a distance of up to 40 m (Fig. 17a). Subsequent high-resolution time-lapse imaging revealed 
live myelination with beginning myelin helix formation (Fig. 17b). Once the helix was formed, 
the myelin turning between the internodes appeared not to be fixed but rather to flow in an 
undulated manner (not shown). 
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Fig. 17 Live myelin outgrowth. (a) Coarse confocal time lapse imaging of PLP-GFP (white) in 
OCS showed live myelination over a distance of up to 40 mm during the time imaged as 
indicated by arrows. (b) high-resolution confocal imaging revealed myelin helix formation 
(asterisk) during myelin outgrowth (arrows). (a and b right panel) Slice view of the respective 
confocal z-stacks confirmed stable slice position in the z-plane and excluded any z-shift related 
misinterpretations. Time elapsed after the start of imaging is shown in the left upper corner. 
Scale bars equal in (a) 50 μm and in (b) 3 μm. 
 
4.2.3 The transition of OLG processes into myelin forms a triangular shape 
The question of how myelin components actually reach the myelin sheath has been discussed for 
long. The thin OLG processes, which appear to merge into the insulating myelin sheath, have 
only seldom been shown by light microscopy, most likely due to resolution problems. In time-
lapse imaging from OLG cell body and processes, we noticed within the process endosomal 
transport of PLP-GFP, suggesting liquid myelin “dough” or micelles being pumped from the 
OLG cell body into the myelin sheath (Fig. 18b). The transition from OLG process to myelin 
sheath could only be visualized by increased exposure and revealed in the slice view a triangular 
shape (Fig. 18a). 
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Fig. 18 Endosomal transport of PLP-GFP in OLG processes that open out in a triangular 
shape into myelin. Increased exposure (a) revealed the rarely visualized transition from OLG 
processes to the myelin sheath forming a triangular shape, confirmed in the respective slice view 
(a). PLP-GFP endosomal transport within OLG processes was observed from the OLG cell body 
to the myelin by performing high-resolution confocal imaging. Time elapsed after the start of 
imaging is shown in the left upper corner. Scale bars equal 3 μm. 
 
4.2.4 The “liquid croissant” model of myelination 
As discussed above, the previous concepts fall short in explaining the formation of myelin 
ensheathment of CNS axons. As we detected an evenly spaced, bidirectional helical turning of 
myelin along the internode in OCS, young and adult mouse CNS irrespectively of the imaging 
method used, we here present our “liquid croissant” model (Fig. 19) in reference to the bi-
directional dough edge spirals of a croissant: (1) myelin lipids/proteins are “poured out” through 
the OLG process like dough, which spreads sideward until it attaches to axonal cell adhesion 
molecules (CAM). (2) While this pouring process continues, axonal CAMs indirectly guide the 
wrapping by being associated with axonal motor proteins that move in a coordinated fashion 
around the axonal cytoskeleton, which results in the turning of the entire myelin/axonal CAMs 
complex. (3) Myelin thickening is thus achieved by new layers forming on top of the inner ones. 
(4) Since the second and subsequent layers originate from the “hose” which spreads in a 
triangular shape onto the layers below, two spiral formations turning in different orientations 
originate to left and right from the location where the “hose” enters the myelin sheath. These 
spirals, formed by laterally expanding surface myelin layers on the top of broader inner layers, 
resemble the dough edges visible on a “croissant”. 
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Fig. 19 The “liquid croissant” model of myelination. Based on our data and recent findings we 
propose that “poured out” myelin lipids/proteins (yellow) attach via the OLG process to axonal 
cell adhesion molecules (cyan). While this pouring process continues, axonal cell adhesion 
molecules indirectly guide the wrapping/spreading by being associated with axonal motor 
proteins that move in a coordinated fashion around the axonal cytoskeleton (turning of the cyan 
line while the myelin is wrapping around). New myelin layers form thus on top of the inner ones 
to achieve myelin thickening. 
 
In conclusion, we hypothesize that the axon is actively involved and guides myelination. In our 
model, new myelin components are “poured” through the OLG process to form new layers on 
top of the inner ones. The proof of our scenario remains to be determined. Yet, this may 
represent one of the most complex problems in myelin research, especially with respect to the 
limited knowledge on the molecular events and interaction partners during active myelination in 
the CNS. 
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5 Discussion 
5.1 The CD4/CD8 T cell misunderstanding in T cell-mediated autoimmunity 
As discussed below, the role of CD8+ T cells in autoimmune research has only recently become 
subject of intense investigation. Despite elegant approaches that strengthen a CD8-mediated 
autoimmune pathogenesis, key questions in MS pathology, such as causes for axonal loss, the 
morphological equivalent to permanent neurological deficits, remained elusive. We have 
therefore investigated whether myelin-specific CD8+ T cells directly attack axons or whether 
axonal loss occurs as result of a targeted hit against myelinated structures indicating “collateral 
bystander damage” 109. 
The turning point in understanding the importance of CD8+ T cells in autoimmune pathogenesis 
was not until recently. Up to then, the pathogenesis of autoimmune diseases was attributed either 
to CD4+ T cells like in MS, rheumatoid arthritis (RA) and diabetes mellitus (DM) type I or to B 
cells like in myasthenia gravis and systemic lupus erythematousus. The two major reasons for 
this were (1) a genetic association with HLA II alleles that present antigen to CD4+ T cells 
35,110
 
and (2) the nature of the respective research tools like EAE, a CD4+ T cell-mediated disease 
111
. 
However, not only show a variety of other autoimmune diseases (like ankylosing spondylitis, 
Behcet’s disease, and psoriasis) an HLA I association 112 but emerging evidence, particularly in 
MS, has broken the ignorance towards CD8+ T cells by the autoimmune research community. 
The preponderance of CD8+ T cells in MS lesions was overlooked for long, most likely due to 
the lack of anti-CD8 antibodies that would label in formalin fixed tissue 
43
. However, the 
pathophysiological consequences of predominating CD8+ T cells in MS lesions 
113,114
 was 
clarified only later by work from Klaus Rajewsky’s group. Sequencing of amplified TCR V-
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regions by single cell PCR allowed the authors to detect particular gene rearrangements that 
derived in majority from CD8+ T cell clones but not CD4 + T cells present in MS lesions 
42
. 
Subsequent complementarity-determining region 3 (CDR3) spectratyping revealed the 
persistence of these infiltrating CD8+ T cell clones in the CSF 
44,115
 and blood 
44
 of MS patients. 
In parallel, the thus suspected pathogenic role of CD8+ T cells in MS was strengthened. For 
example, myelin-specific CD8+ T cells in the blood of MS patients appeared to proliferate in the 
presence of peptides from various myelin proteins 
45,116
. Likewise, numbers of infiltrating CD8+ 
T cells could be correlated with the extent of axonal damage in MS lesions 
117
. Complementary, 
MHC class I expression was claimed to be up-regulated in MS lesions on OLG and neurons 
118
. 
However, small case numbers and insufficient immunostainings in the latter study leave MHC 
class I expression, especially on axons, questionable. 
That myelin-specific CD8+ T cells can cause autoimmune damage was found in two independent 
experimental models. In one set-up, adoptively transferred MOG-specific CD8+ T cells from 
MOG35-55/CFA-induced EAE animals prompted EAE like symptoms in WT or RAG1
-/-
 recipient 
mice. Interestingly, the authors were unable to induce adoptive transfer EAE with these MOG-
specific CD8+ T cells in MHC class II 
-/-
 deficient animals 
49
. In the other approach, MBP-
specific CD8+ T cells were isolated from MBP
-/-
 or WT mice immunized with a previously 
identified peptide MBP79-87 
119
. Adoptive transfer of MBP-specific CD8+ T cells into WT or scid 
recipient mice resulted in fulminant EAE but was absent in MBP
-/-
 mice 
50
. 
However, in both studies only few CD8+ T cells infiltrated the brain. To study therefore CD8+ T 
cell CNS infiltration, CL4 mice, carrying CD8+ T cells with a transgenic TCR for the influenza 
virus hemagglutinin (HA) 512-520 antigen 
120
 received intrathecal injections of their cognate 
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antigen or the control peptide Cw3. An accumulation of HA-specific CD8+ T cells was only seen 
in case of the specific HA-antigen and was claimed to dependent on MHC class I expression by 
cerebral endothelium but not on perivascular macrophages that had been depleted by clodronate-
loaded liposomes 
121
. Although an endothelial contribution to T cell brain infiltration certainly 
exists 
122
, limiting this involvement solely to MHC class I expressing endothelium appears too 
simplified, especially as the “proof” relied on MHC class I antibody depletion only. 
As the CD8+ T cell-mediated EAE models revealed demyelination that was associated with 
broad tissue damage reminiscent of ischemic injury, two independent groups used CD8+ T cells 
specific for a neo-self antigen restricted in its expression to OLG to investigate the direct impact 
of CD8+ T cells on myelin. In one approach, the authors generated Rosa
26tm(HA)1Libl
 mice, in 
which the influenza virus hemagglutinin (HA) sequence was introduced in the ubiquitously 
active Rosa 26 locus flanked by a LoxP stop cassette. Rosa
26tm(HA)1Libl
 mice were crossed with 
MOGi-Cre mice 
123
 to allow expression of HA solely in OLG (then referred to as DKI mice). 
Adoptive transfer of in-vitro stimulated and GFP labeled CD8+ T cells carrying a transgenic 
TCR for the HA512-520 derived from CL4 transgenic mice 
120
 caused severe neurological 
symptoms in DKI but not in WT mice. Pathological analysis confirmed CD8+ T cell infiltrates in 
CNS lesions with demyelination 
51
. In the other approach, the authors used transgenic ODC-
OVA mice that express the neo-self antigen OVA solely in OLG 
103
. Adoptive transfer of OT-I T 
cells in 2-week-old ODC-OVA x RAG-1
-/-
 recipient mice resulted in spontaneous EAE by 
invading CD8+ T cells. The observed neurological symptoms were equally found in ODC-OVA 
x RAG-1
-/-
 animals crossed with OT-I mice. Interestingly, in their set-up EAE occurred only in 
2-week-old mice and was most pronounced in the RAG1-/- lymphopenic environment 
52
. 
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5.2 CD8+ T cell-mediated target cell death 
Despite their elegancy, neither of the discussed studies addressed the direct impact of CD8+ T 
cells on CNS tissue damage and especially lacked the question in which fashion CD8+ T cells 
may contribute to axonal damage. 
The key finding of our study was that “innocent” axons were damaged by an apparently 
imprecise targeting of myelin-specific CD8+ T cells. We proved this “collateral bystander 
damage” of axons by restricting cognate antigen expression to OLG, which appear to efficiently 
present peptides processed from endogenous protein to auto-aggressive cytotoxic CD8+ T cells. 
Later, our results that “collateral bystander damage” causes axonal loss were confirmed by others 
124
, raising the question towards the underlying mechanism leading to CD8-mediated 
neurotoxicity. 
In general, CD8+ T cells only respond to their cognate peptide antigens (8–11 amino acids in 
length) when presented by MHC class I molecules 
125
. In experimental models, MHC class I 
expression on OLG was shown in-vitro 
47,126
 and in-vivo 
127
 under inflammatory conditions. 
Likewise, we found that MHC class I expression on OLG was induced by IFN However, MHC 
class I expression on neurons remains controversial. With the assumption that infected or 
damaged neurons reside in an inflammatory environment and have a disrupted electrical 
function, dissociated neurons were electrically silenced and treated with IFN. Only under these 
rather artificial conditions MHC class I expression could be detected 
128
. In-vivo, inflammation 
with attenuated murine hepatitis virus caused MHC class I expression in the neuronal cytoplasm 
but not on dendrites or axons 
127
. Yet, the neuron –specific enolase (NSE) marker used for 
neuron identification has been described to coincide with differentiating OLG 
129
 so that an 
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additional neuronal marker would have been desirable. As we could not formally exclude MHC 
class I expression on neurons, we challenged and verified our findings by incubating OCS with 
complete ovalbumin protein. We based this investigation on a hypothetical scenario, in which 
myelin proteins would be released by myelin damage. Subsequent extracellular digestion could 
potentially lead to loading of myelin protein derived peptides onto an accessible MHC class I 
positive cell, including axons, thus enabling CD8+ T cells to attack axons themselves. Yet, we 
could not detect any CD8-mediated axonal damage when mimicking myelin release by 
ovalbumin addition. Apparently, extracellular processing of complete 385 amino acid long 
ovalbumin protein specifically to the cognate SIINFEKL peptide is a rather rare event in OCS. 
With respect to our observation that myelin and axons did not express MHC class II molecules as 
described previously 
118
, CNS tissue integrity in the presence of OT-II or 2D2 transgenic CD4+ 
T cells was expected. It is therefore remarkable that PLP-specific CD4+ T cells were claimed to 
induce CNS damage in a non-MHC class II restricted fashion 
39
. Possible reasons explaining 
these controversial observations may be: (1) Nitsch et al employed acute hippocampal brain 
slices from SJL/J mice, a strain known to be more susceptible to CD4-mediated EAE than the 
C57BL/6
 
(B6) mice we used; (2) Long-term cultures and re-stimulation of antigen specific CD4+ 
T cells is known to select for a T cell phenotype acquiring lymphokine-activated killer (LAK) 
properties 
130
 reminding of NK cells 
131
; (3) CD4+ T cell-mediated neuronal damage was claimed 
by changes in cellular calcium concentrations, visualized by the cell-permeable Ca
2+
-indicator 
Fluo-4, which is however not proof of axonal damage. As such, most likely the different 
experimental set-ups and read-outs account for the controversial finding. 
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The mechanisms which may cause axonal damage by CD8+ T cells appear not entirely clear yet. 
As discussed below, not the mere presence of CD8+ T cells but the integration of different 
signals, like TCR signaling, chemokine pattern and type of employed CD8+ T cell appear to 
decide on the outcome of CD8+ T cell effector functions. Recently, for example, the paradox 
was clarified how apparently healthy neurons latently infected by herpes simplex virus (HSV)-1 
can be surrounded by CD8+ T cells without being damaged. In their study, the authors found that 
CD8+ T cells selectively cleared virus without killing infected neurons by employing non-lytic 
mechanisms like release of IFN but majorly by the direct proteolytic activity of granzyme B 132. 
In turn, in the model of acute viral meningoencephalitis, CD8+ T cells were found to 
chemoattract monocytes and myelocytes, which then cause CNS damage 
133
. 
In the classic view, CD8+ T cells form an immune synapse with their target cell upon 
recognition 
134
. This may occur even at low numbers of antigen-presenting MHC class I 
molecules on the target cell, in our case OLG 
135
. In the next step, both high- and low-avidity 
MHC class I-TCR interactions lead to centrosome polarization, yet only high-avidity interactions 
increase TCR signaling that recruits lytic granules to the polarized centrosome 
136
. The 
subsequent polarized release of lytic granules is thought to spare surrounding tissue. We also 
found polarization of lytic granules but observed collateral bystander damage of axons. This 
raises the question whether myelin and axon are too closely engaged to kill the one and spare the 
other or if our observation was related to the CD8+ T cells used. 
We previously observed that anti-MOG antibody together with complement could induce a 
demyelination in slices without damaging axons 
137
, which appears in comparison with a CD8-
mediated damage rather targeted. T cells carrying transgenic TCRs are often criticized for that 
they may not accurately model endogenous T cell responses. We used OT-I transgenic T cells 
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that were originally selected and subcloned from CTLs derived from OVA-immunized B6 mice 
138
. Based on their TCR identity, OT-I transgenic mice were then generated carrying these 
SIINFEKL-specific CD8+ T cells 
139
. As other TCR transgenic strains, OT-I mice hold 
unphysiological numbers of CD8+ T cells expressing the transgenic OVA TCR and are strongly 
cytolytic towards OVA-expressing target cells 
139,140
, even in the absence of classical co-
stimulatory molecules like CD80/86 
52
. Therefore, the choice of OT-I CD8+ T cells may have 
influenced our findings. Yet, the lack of alternative CD8+ T cells tools appears to justify their 
broad use in autoimmune research and may still be indicative for further understanding. 
5.3 Axonal molecules that initiate and regulate myelination 
A growing number of observations points to a prominent role of axons in proper myelination and 
myelin maintenance 
141
. Accordingly, myelination is thought to be orchestrated by the balance of 
stimulating and inhibitory axonal factors that can be either expressed on the axonal surface or 
represent soluble mediators 
142
. 
The first evidence that rather axonal signals than an intrinsic myelination program of the glial 
cell regulates myelination came from the pioneer studies by Aguayo et al. The authors observed 
that Schwann cells were able to make myelin in the presence of a regenerating nerve, although 
they had not made any myelin before 
143
. While oligodendrocyte precursor cells (OPC) can 
proliferate and differentiate into postmitotic OLG in neuron-free cultures 
144
, specific axonal 
signals for proper OLG myelin formation are required. For example, the ratio of axon diameter 
to myelin thickness (called g-ratio) was shown to remain constant 
145
. Similarly, OLG that had 
only been myelinating small caliber optic nerve fibers, were demonstrated to form proper size-
adjusted myelin sheaths, when transplanted to larger spinal cord axons 
146
 or when the axon 
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caliber was reduced 
147
. Likewise, under healthy conditions previously unmyelinated CNS axons 
retain their ability to become myelinated as shown by myelination of retinal axons after 
transplantation of CG-4 cells, an OPC cell line 
148
. Furthermore, specific recognition molecules 
on the axonal surface seem to be pivotal, as OLG form true, spirally wrapped myelin sheaths in-
vitro solely around axons but not dendrites 
149
. 
Despite this clear axonal influence on myelination, only little is known about the exact 
underlying mechanisms, especially in the CNS. Up to date, type III neuregulin-1 (NRG1) 
expressed on axons is the only identified molecule that was shown to determine both myelin 
formation 
150
 and myelin sheath thickness 
151
 in the PNS. Yet, its role in the CNS is clearly 
distinct, as NRG1 deficient mice lack any CNS phenotype 
152
. Regarding myelin maintenance, 
cellular prion protein (PrP
c
) expressed by neurons was recently implied to play an essential role 
in the PNS, while its function in the CNS remains less clear given myelin integrity in Prnp
o/o
 
mice 
153
 . Apart from that, a few axonal-glial interaction partners were suggested to influence 
myelination. Laminin-2 was proposed to interact with an OLG integrin, based on the 
observations that (1) OLG produce increased myelin sheaths when cultured on laminin-2 
154
, (2) 
laminin-2 absence causes dysmyelination in mice 
155
 and humans 
156
 and (3) antibody-blocking 
experiments 
157
 or OLG deficient for 1 integrin display decreased-absent myelination 158. 
Recently, OLG contactin, a glycosylphosphatidylinositol (GPI)-anchored CAM of the Ig family 
was proposed to interact with the axonal CAM L1 that signals together with the OLG integrin/ 
axonal laminin-2 complex through Fyn activation 
159
. 
Moreover, axonal binding partners can also inhibit myelination. The axonal polysialted neural 
cell adhesion molecule (PSA-NCAM) was observed to correlate inversely with the myelin sheath 
thickness in-vivo 
160
, to be down-regulated by the onset of myelination 
161
 and to be up-regulated 
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during demyelination in-vitro 
162
. Likewise, Notch1 expressed by OLG 
163
 was described in-vitro 
and in-vivo to bind to its ligand Jagged 1, which is expressed by axons to inhibit OPC 
differentiation 
164
 and OLG myelination 
165
. 
Taken together, only a few axonal-glial interaction partners and mechanisms are known and 
future studies are needed to better understand the structural and molecular changes in axon and 
OLG during myelination. 
5.4 Indications that axonal energy is required for myelination 
Clearly, energy has to be consumed in order that myelin can achieve its sophisticated 
cytoarchitecture, a fact that has not thoroughly been investigated up to this date. In-vitro, OLG 
processes were claimed to contain mitochondria 
166
 but not a single EM study has described 
conclusively mitochondria within the growing myelin inner loop. This lack of evidence is not 
surprising given the relatively large-sized mitochondria that would have to fit in the small 
cytoplasmic inclusions of the inner loop. Yet, the energy source for myelination remains elusive. 
In this context, ATP could formally (1) diffuse over long distance from the OLG cell body 
through the process to the growing part, a rather rare event 
167
, (2) be taken up from an 
extracellular source although ATP then serves paracrine signaling in general 
168
 or (3) ATP could 
be produced and consumed within the axon for myelination to occur. 
Several recent findings indirectly support the latter possibility by approving an axonal support in 
myelination that goes beyond simple adhesion. For example, only pseudomyelin structures that 
lack the tight compact characteristic of proper myelin, were described to form around PFA-
fixated, thus dead, axons 
169
, which are similarly observed without co-cultured axons 
170
 or in the 
presence of carbon fibers 
171
. While this undoubtedly demonstrates an intrinsic myelin formation 
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program within the OLG, it implicates that more is required than simple axonal recognition 
signals for proper myelination to occur. In line, only healthy axons that activity-dependently 
release ATP become myelinated 
172
, whereas blockage of axonal activity with the sodium 
channel-specific neurotoxin tetrodotoxin (TTX) inhibits myelination 
173
. Recently, axonal 
mitochondria were described to change size and distribution dependent on the demyelination or 
remyelination status 
174
. That an active axonal process in myelination may be needed for 
myelination is further supported by studies of the major kinesin motor protein in the CNS, 
KIF1B, which is involved in axonal transport of mitochondria and synaptic vesicles 
175
. Its 
impairment was associated with hypomyelination and Charcot-Marie-Tooth disease type II 
176
 
and is discussed in MS susceptibility 
177
, an astonishing finding with respect to a primary 
dysfunction within the axon that should theoretically not affect myelination per se. 
Besides a potential function as energy source, we propose that the axon may directly guide 
outpoured myelin along the internode by molecules like the axonal cell adhesion molecules caspr 
(contactin-associated protein) 
178,179
 and contactin which interact with glial neurofascin (NF) 155 
180
. Accordingly, caspr was described to bind with its cytoplasmic domain to protein 4.1 
178
, 
which in turn binds to the axonal actin skeleton 
181
. In addition, mice lacking either caspr 
182
 or 
contactin 
87
 fail to assemble myelin properly, most pronouncedly observed at the paranode. 
Furthermore, caspr is initially homogenously distributed along the axon and achieves its 
characteristic helical pattern only upon myelination 
179
, which was previously suggested to 
mirror myelination 
98
. Moreover, we believe that our hypothesis is also in favor from an 
evolutionary point of view, as axons apparently depend more on myelination 
63
 than the 
myelinating cell on the axon. 
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5.5 Developmental myelination versus remyelination 
Various aspects closely connect the understanding of myelin formation with the pathological 
state of demyelination and its regenerative process, remyelination. Remyelination is thought to 
mainly influence the outcome of demyelinating diseases, such as MS and is therefore intensely 
studied. In theory, similar mechanisms to those described for developmental myelination could 
take place for remyelination. Yet, the past decades of remyelination research were dedicated to 
the clarification whether remyelination occurs from surviving OLG that regenerate their “just” 
lost processes and myelin sheaths or from invading progenitor cells that differentiate into 
remyelinating OLG. As discussed below, up to date neither possibility has been truly resolved 
and in addition, the main molecular similarities and differences between developmental myelin 
formation and remyelination remain elusive. 
In the CNS, the loss of myelin is usually the result of primary and not secondary demyelination, 
in which myelin degenerates as consequence of primary axonal loss. Primary demyelination is 
either caused by genetic abnormalities within OLG (like leukodystrophies) or - in terms of 
morbidity more significant - by an inflammatory damage of myelin/OLG (like in MS). 
Regardless of the cause, the loss of myelin results in an acute conduction block that is resolved 
by an even distribution of Na
+
 channels to allow non-saltatory conduction along the 
demyelinated internode 
183
. This deficit can be solved by remyelination, which restores the 
myelin sheath and thus repairs saltatory conduction and functional deficits. Interestingly, the 
original dimensions of myelination are not entirely reestablished during remyelination showing a 
thinner and shorter myelin sheath than expected 
184,185
, making remyelinated lesions appear less 
intense with myelin stains (so-called “shadow plaques”). 
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The models in which demyelination is induced to study remyelination typically employ toxins, 
like dietary cuprizone or injected lysolecithin, traumatic injury, viral infections or immune-
mediated mechanisms like in EAE 
186
. Using these models, only a few differences between 
developmental myelination and remyelination have been elucidated. For example, the 
transcription factor OLIG1 is thought to be essential for developmental myelination but appears 
to play a redundant role in OPC differentiation during remyelination 
187
. Likewise, conditional 
NOTCH1 knockout from OPC did not influence remyelination 
188
 while Notch receptor 
activation inhibits OLG differentiation during myelination as discussed above. Despite different 
pathoetiologies in the classic demyelination models, certain key features appear to be shared. 
Firstly, axonal survival is indispensible for remyelination. Environmental mediators may cause 
however secondary axonal damage of the “naked” axon. Demyelinated axons were described to 
suffer from disturbed mitochondrial function, pathological Na
+
 influx which subsequently causes 
Ca
2+
 influx 
189
 which in turn activates intra-axonal proteases resulting in neurofilament 
breakdown and perturbation of axonal transport 
190
 and integrity 
191
. In addition, the 
demyelinated axon is implicated itself in inhibiting remyelination by expressing PSA-NCAM 
162
 
(as discussed above) or LINGO-1 (Nogo-receptor interacting protein) which inhibits myelination 
by interacting with the Nogo receptor complex. The disruption of LINGO-1 promotes OPC 
differentiation and OLG myelination independent of axonal caliber 
192
. In view of our hypothesis 
and the few identified axo-glial interaction partners discussed above, it is intriguing to speculate 
that compromised remyelination could result from impaired axons that have undergone too 
dramatic intrinsic changes to recruit OPC (see below) and direct remyelination. 
Secondly, the currently most accepted and compelling notion suggests that adult OPC 
193
 migrate 
to demyelinated areas, similarly to the process during developmental myelination 
194
 and 
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differentiate into myelinating OLG 
195
. OPC are commonly identified by – the not exclusive - 
expression of proteoglycan NG2, platelet-derived growth factor receptor- (PDGFR) or the 
transcription factor OLIG1 
196
. Yet, all evidences for an OPC involvement in remyelination 
remain indirect: (1) autoradiographic tracing has identified dividing cells that give rise to 
myelinating OLG but these cells were not proven to be OPCs 
197
, (2) transplanted OPCs were 
shown to remyelinate demyelinated areas 
198,199
, (3) OPCs repopulate demyelinated areas before 
new OLG appear 
200
 and (4) the failure of remyelination was associated with an age-dependent 
decrease in OPC recruitment and differentiation 
201
. In contrast, the migration of post-mitotic 
OLG to a demyelinated area seems unlikely and even their local participation was negated. 
However, both studies carried major caveats as they employed OLG, which had either been 
subjected to a high dose of X-ray radiation 
202
 or were maintained in-vitro 
203
, both conditions 
that are likely to cause disturbances in cell function. As such, remyelination may recapitulate 
certain features of developmental myelination but deeper insight into cellular and molecular 
mechanisms or axo-glial interaction partners is needed to conclusively understand this 
regenerative process. 
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5.6 Concluding remark 
We here presented two important findings with respect to CNS (patho)physiological events. 
Fully aware that the outlined CD8+ T cell scenario is most likely not the only relevant 
mechanism of CNS tissue damage in inflammatory CNS diseases, we are confident that our 
findings critically contribute to the understanding of CD8-mediated neuropathology in CNS 
inflammation, strengthen a pathogenic role of CD8+ T cells in MS and advocate for the 
development of future immunotherapies aiming at the CD8-myelin/OLG interface. In addition, 
we are convinced that the “liquid croissant” model describing fluid myelin to be guided by an 
energy consuming process within the axon to achieve myelination, reshapes the current 
understanding of myelin formation and may explain myelination deficits in remyelination and 
axonopathies. 
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